Catheterization is particularly useful in the diagnosis of occult systemic to pulmonary shunts, congenital heart disease, and distal pulmonary artery stenosis.
Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana ...
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback